Supplemental Examination: 5 Smart Ways to Save a Patent

One overlooked prior-art reference can quietly poison an entire patent. If an accused infringer later proves you withheld material information with intent to deceive, a court can hold the patent unenforceable for inequitable conduct — the “atomic bomb” of patent defenses. Supplemental examination is the tool Congress built to defuse it. Codified at 35 U.S.C. § 257, it lets a patent owner ask the USPTO to consider information that should have been reviewed during prosecution — and, handled correctly, it shields the patent from an unenforceability attack based on that information. This guide covers how it works, the substantial-new-question test, the timing traps that waste it, and five smart ways to use it.

What Supplemental Examination Is

Supplemental examination is a proceeding, available since September 16, 2012, that lets a patent owner request the USPTO to “consider, reconsider, or correct information believed to be relevant to the patent.” It is set out in 35 U.S.C. § 257. Unlike ex parte reexamination, the request is not limited to patents and printed publications — the information can be almost anything: a mistranslation, a prior sale, an inconsistent litigation statement, or a reference that never made it into the file.

The headline benefit lives in § 257(c). Information that is considered, reconsidered, or corrected during a completed proceeding cannot later be used to hold the patent unenforceable for inequitable conduct. In plain terms, you get to clean the file yourself, on your own timeline, before an opponent turns the same information into a weapon in court.

That combination — broad inputs and a statutory shield — is what makes the mechanism unusual. Most post-grant proceedings put a patent at risk. This one is designed to protect it.

Why It Matters: Curing Inequitable Conduct

Inequitable conduct is uniquely destructive. A single proven instance can render every claim of a patent unenforceable, and the taint can spread to related patents in the same family. The Federal Circuit raised the bar in Therasense v. Becton, Dickinson, 649 F.3d 1276 (Fed. Cir. 2011) (en banc), requiring both but-for materiality and a specific intent to deceive.

Even after Therasense, the mere allegation is costly. It drags accused infringers into expensive discovery, invites fee-shifting fights, and clouds a patent’s value in licensing talks and acquisition diligence. Buyers discount what they cannot verify, and a defendant who smells an unclean file will spend heavily to prove it. The uncertainty alone can knock a patent out of a settlement negotiation before its claims are ever tested on the merits.

A supplemental examination attacks the problem at its root. By placing the troublesome information formally before the USPTO and letting the Office act on it, you remove the “withholding” that an inequitable-conduct charge depends on. Pair the filing with a disciplined prior-art search and clean disclosure practice, and you close the door before anyone tries to open it. Our guides on inequitable conduct and prior-art searching cover the underlying risk in depth.

The SNQ Test and the Reexamination Bridge

Once you file, the USPTO has three months to decide whether the items of information raise a substantial new question of patentability (SNQ) — the same threshold used in reexamination. Two outcomes follow.

• No SNQ. The Office issues a certificate and the proceeding ends. The information is now part of the record and shielded from an inequitable-conduct charge.
• SNQ found. The Office orders ex parte reexamination of the patent on those questions. That reexamination proceeds under § 257(b), except the patent owner does not get to file the usual opening statement.

So the process can flow into ex parte reexamination. That is not a failure. If a reference truly raises a genuine question, you want the claims tested and confirmed or amended now, on your terms, rather than in front of a jury later. Certainty gained early is worth more than a fragile presumption of validity.

Timing Traps That Waste the Benefit

The immunity in § 257(c) has two exceptions, and both turn on timing. Miss either and the whole exercise fails to protect you.

1. The shield does not apply to an inequitable-conduct allegation that was pled with particularity in a civil action, or stated in a Paragraph IV Hatch-Waxman notice, before the request is filed.
2. In a patent enforcement action, the shield applies only if the proceeding — and any reexamination it triggers — is concluded before the enforcement suit is brought.

The lesson is blunt: this is a proactive tool, not a litigation rescue. File early — ideally as part of pre-assertion diligence — not after a defendant has accused you and not after you have sued. Wait until a dispute is live and you usually forfeit the very protection you paid for.

One more caution. Under § 257(e), if the Office comes to believe during the proceeding that a material fraud may have been committed on the USPTO, it can refer the matter to the Attorney General. This mechanism cleans up honest omissions and mistakes; it is not cover for deliberate deception.

Cost, Procedure, and What to File

A single request can include up to twelve items of information, and each item must be explained — what it is and how it bears on the patent’s claims. You pay a supplemental examination fee plus a reexamination fee up front. The reexamination portion is refunded if the Office decides no reexamination is warranted.

The combined fees are substantial, so budget several thousand dollars, and confirm the current numbers before filing because the USPTO updates its fee schedule periodically. For a patent that anchors a product line or a licensing program, that cost is small next to the price of losing enforceability in the middle of a case. Weigh it the way you would any insurance premium: the value shows up only when something goes wrong, but by then the protection has to already be in place.

Procedurally, the request reads like a focused prosecution paper: identify each item, tie it to specific claims, and explain its relevance plainly without arguing away materiality. Precision matters, because only the information you actually place before the Office is protected. A thorough, well-scoped submission is worth the drafting effort — a sloppy one leaves gaps an opponent will find.

5 Smart Ways to Put It to Work

1. Pre-assertion cleanup. Before you sue or send a demand letter, cure any known disclosure gap so an inequitable-conduct defense never gets off the ground.
2. Pre-transaction diligence. Strengthen a patent’s standing before licensing it or selling the portfolio, when buyers scrutinize enforceability hardest.
3. Fixing a missed reference. Formally submit prior art or a foreign counterpart that should have been disclosed during original prosecution.
4. Correcting the record. Address a mistranslation, an inconsistent declaration, or an early sale that could later look like concealment.
5. Confirming key claims. When a reference raises a genuine question, let the resulting reexamination validate or tighten the claims before an adversary forces the issue.

Used early and deliberately, the tool converts a latent vulnerability into a settled record. Used late, it does little but drain fees. The difference is planning — and a clear-eyed audit of the file before you rely on the patent.

How PerspireIP Can Help

A patent is only as strong as its file history. PerspireIP helps owners identify disclosure gaps, run the prior-art searches that surface hidden risk, and prepare the requests that shield key assets before litigation or a deal puts them under a microscope. Contact our team to review a patent’s enforceability before you rely on it.

Frequently Asked Questions